Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.







25.09.2020
Disclosed inside information pursuant to article 17 Market Abuse Regulation (MAR) transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
Earnings Forecast 25.09.2020
Vienna, Austria - 25 September 2020 - Semperit AG Holding published an ad hoc release on 3 July of this year announcing an outlook with earnings significantly above those of the previous year. The earnings forecast will now be increased again.
In addition to the positive effects from the medical business for the foreseeable future, the Industrial Sector has now also slightly recovered compared with earlier assumptions regarding the effects of the global recession and the developments surrounding the corona pandemic. Against this background and based on current figures, EBITDA of the Semperit Group for the full year is expected to range between EUR 165.0 and 200.0 million, thus exceeding the previous year's value (2019: EUR 67.8 million) more clearly than assumed in July. Accordingly, EBIT of the Semperit Group for the full year 2020 will be between EUR 195.0 and 230.0 million (forecast in July 2020: EUR 110.0 to 160.0 million; EBIT 2019: EUR -16.5 million). The earnings forecast depends, in particular, on the further development of the price level for medical protective gloves and the sufficient availability of raw materials for their production.
The strategic landmark decision made in January to transform the Semperit Group into an industrial rubber specialist is still valid. However, in view of the extremely positive earnings contributions that the glove business is currently making in the context of the pandemic-related exceptional economic situation, Semperit will probably continue to run the medical division for at least nine more months before actively working on the decided separation from the medical business again.
end of announcement euro adhoc
issuer: Semperit AG Holding Modecenterstrasse 22 A-1030 Wien phone: +43 1 79 777-310 FAX: +43 1 79 777-602 mail: judit.helenyi@semperitgroup.com WWW: www.semperitgroup.com ISIN: AT0000785555 indexes: WBI, ATX GP, ATX PRIME stockmarkets: Wien language: English
Digital press kit: http://www.ots.at/pressemappe/2918/aom
 

Bildnachweis

1. Semperit Produktionsstätte Wimpassing auf unserer Finanzmap für Österreich http://www.boerse-social.com/finanzmap   >> Öffnen auf photaq.com



Aktien auf dem Radar:Lenzing, Marinomed Biotech, Semperit, Addiko Bank, FACC, SBO, Strabag, Rosgix, Rosenbauer, AT&S, Erste Group, EVN, Verbund, Immofinanz, Mayr-Melnhof, OMV, Uniqa, ATX, Polytec Group, ATX Prime, S Immo, voestalpine, Wienerberger, UBM, Bawag, AMS, Andritz, Flughafen Wien, Wolford, Zumtobel, Signature AG.


Random Partner

HSBC
HSBC Deutschland ist Teil der HSBC-Gruppe und kann daher auf eines der größten internationalen Netzwerke zugreifen. HSBC Trinkaus & Burkhardt AG beschäftigt in Deutschland über 3.000 Mitarbeiter an 12 Standorten. Das Finanzinstitut kann bei der Emission von Anlagezertifikaten und Hebelprodukten auf mehr als 30 Jahre Erfahrung zurückschauen.

>> Besuchen Sie 58 weitere Partner auf boerse-social.com/partner


Mehr aktuelle OTS-Meldungen HIER